Olfen-75 solution for injection, 2ml x 5 ampoules — Made in Germany by Teva — Free Delivery

The preparation is prescribed in the form of intramuscular injections in the following conditions:

- inflammatory or degenerative forms of rheumatism, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondyloarthritis, vertebral pain syndrome, extra-articular rheumatism;

- acute attacks of gout

- renal and hepatic colic;

- pain, inflammation and swelling after trauma and surgery

- severe migraine attacks.

active ingredients: diclofenac sodium, lidocaine hydrochloride 1 ampoule (2 ml) contains diclofenac sodium 75 mg and lidocaine hydrochloride 20 mg Excipients: sodium edetate, acetylcysteine, propylene glycol, polyethylene glycol 400, sodium hydroxide, water for injection.

The dose is selected by the doctor individually. The preparation should be used in the most effective doses for a short period of time, taking into account the purpose of treatment for each patient. Before using the preparation Olfen®-75, it is necessary to carry out a skin test for hypersensitivity to lidocaine hydrochloride. Olfen®-75 is used as an injection. In connection with the possible appearance of anaphylactic reactions, up to the development of shock, after the administration of the preparation Olfen®-75, the patient should be monitored for at least 1:00, while the funds necessary for the provision of emergency medical care should be at the ready. The usual single dose of the preparation is the contents of 1 ampoule (i.e. 75 mg of diclofenac sodium), which is injected intramuscularly 1 time per day by deep injection into the upper outer quadrant of the gluteus maximus muscle. The solution should be used immediately after opening the ampoule. Any unused solution must be discarded. In case of severe pain (for example, colic), the preparation can be administered 2 times a day at intervals of several hours, always changing the injection site. The combination of parenteral administration of Olfen®-75 with other dosage forms of Olfen® preparations (tablets, capsules, rectal capsules, gel or patch) is permissible, provided that the maximum daily dose of diclofenac sodium does not exceed 150 mg. In conditions of a migraine attack, clinical experience is limited to cases with the initial use of one ampoule of 75 mg, the dose should be administered as soon as possible after the use of suppositories of 100 mg on the same day (if necessary). The total daily dose should not exceed 175 mg on the first day. There is no data available on the use of Olfen®-75 for the treatment of migraine attacks for more than 1 day. The duration of parenteral administration of Olfen®-75 should not exceed 2 days. If necessary, treatment can be continued with Olfen®-50 Lactab, Olfen®-100 CP Depocaps, Olfen®-100 Rectocaps. Do not use Olfen®-75 for injection / infusion. Elderly patients dose adjustment is not required, but due to the possible occurrence of adverse reactions, it is necessary to monitor elderly patients with particular care. Patients with impaired renal or hepatic function 10 In patients with impaired renal or hepatic function, mild to moderate dose reduction is not required.

Children.

Not intended for use in children.